Physician profile
John H Rundback
NPI 1255367280
$507,494.80
in general payments reported to CMS, 2019-2025
50 companies · $54K in 2025
The $54K reported for 2025 was more than what 97% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $56K · 2020: $79K · 2021: $100K · 2022: $123K · 2023: $50K · 2024: $45K · 2025: $54K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $55K · Long Term Medical Supply Or Device Loan: $48K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Food and Beverage: $11K · Travel and Lodging: $9,433 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $5,568 · Honoraria: $4,225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $55,262.50 |
| Long Term Medical Supply Or Device Loan | $47,772.22 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,665.00 |
| Food and Beverage | $10,844.79 |
| Travel and Lodging | $9,432.81 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $5,567.50 |
| Honoraria | $4,225.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $209,560.54 | 2019-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac, Angiovac |
| Cardiovascular Systems INC. | $72,357.53 | 2019-2023 | Diamondback Peripheral |
| Inari Medical, INC. | $45,693.47 | 2019-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $39,163.65 | 2019-2025 | Esprit, Diamondback Peripheral, Jeti Peripheral Catheter |
| Bard Peripheral Vascular, INC. | $33,834.41 | 2019-2025 | Venovo, Denali Vena Cava Filter, Covera |
| Medtronic, INC. | $27,379.73 | 2022-2025 | In.Pact Admiral, Hawkone, Abre |
| Philips North America LLC | $20,775.29 | 2019-2025 | (9520) Igt Devices Undivided, Igt Devices Undivided |
| Janssen Pharmaceuticals, INC | $15,035.29 | 2019-2024 | Xarelto |
| Medtronic Vascular, INC. | $8,060.96 | 2019-2020 | |
| Shockwave Medical, INC | $6,559.85 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave M5+, Shockwave S4 |
| W. L. Gore & Associates, INC. | $6,528.73 | 2019-2025 | Product In Development, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Endoprosthesis |
| Boston Scientific Corporation | $3,397.20 | 2019-2025 | Enroute Transcarotid Neuroprotection System, General - Vascular Intervention |
| Inquis Medical, INC. | $2,980.77 | 2024 | Aventus |
| Vesper Medical | $2,811.16 | 2021 | |
| Silk Road Medical, INC. | $2,366.76 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $1,711.66 | 2022-2023 | Brite Tip |
| Teleflex LLC | $1,400.00 | 2024 | |
| Veryan Medical Incorporated | $1,388.32 | 2020-2025 | Biomimics 3d Vascular Stent System |
| Endologix LLC | $1,126.76 | 2022-2025 | Torus Stent Graft System, Endocross Device |
| Asahi Intecc USA, INC. | $1,000.00 | 2021-2023 | |
| Intact Vascular, INC. | $694.07 | 2019 | |
| Cook Incorporated | $655.00 | 2021 | |
| Contego Medical, INC | $599.69 | 2024-2025 | |
| Stryker Corporation | $315.02 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Artix Mt |
| Cook Medical LLC | $282.25 | 2019-2024 | Cook |
| Cardinal Health 200 LLC | $280.12 | 2019-2021 | |
| Neuros Medical, INC. | $223.00 | 2025 | Altius |
| Convatec INC. | $216.48 | 2024 | |
| Sirtex Medical INC | $210.21 | 2019-2025 | Sir-Spheres Microspheres |
| Medtronic USA, INC. | $145.10 | 2019 | |
| Siemens Medical Solutions USA, INC. | $109.01 | 2019 | |
| Biotronik INC. | $101.23 | 2022-2024 | Pulsar-18 T3 |
| Cardiva Medical, INC. | $88.32 | 2021-2022 | |
| Limflow INC. | $85.32 | 2023 | Limflow System |
| Baylis Medical Technologies INC. | $66.58 | 2025 | |
| Reflow Medical INC | $58.83 | 2023-2025 | |
| Globus Medical, INC. | $51.60 | 2025 | Senza |
| Smith+Nephew, INC. | $33.24 | 2023-2024 | Collagenase Santyl |
| Penumbra, INC. | $27.08 | 2021-2023 | Indigo System |
| Imperative Care, INC | $27.03 | 2025 | Symphony Catheter |
| Kerecis Limited | $20.16 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Terumo Medical Corporation | $18.89 | 2020 | |
| Paratek Pharmaceuticals, INC. | $15.55 | 2024 | Nuzyra |
| Tactile Systems Technology INC | $14.21 | 2021 | |
| Venturemed Group, INC. | $13.81 | 2021 | |
| Getinge USA Sales, LLC | $10.92 | 2019 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$29,698.51 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Rundback listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.